Welcome and Panel 1

Presiding Officer Opening Remarks
Douglas Throckmorton, MD
Deputy Center Director, Center for Drug Evaluation and Research, FDA

Theresa Kroll, Parent

Ada Giudice-Tompson, Patient Advocate

Avi Israel, Patient Advocate

Pete Jackson, Advocates for the Reform of Prescription Opioids

FDA Questions

Wendy Foster, U.S. Pain Foundation, Inc.

Zxy Atiywariii, Patient

Cynthia Ralls, Patient and Advocate

Sarah Bowker, Patient and Survivor

FDA Questions

Panel 2

Robert Twillman, Health Professional Organization

Edward Manougian, Clinician

Ronald J. Crossno American Academy of Hospice and Palliative Medicine

Charles Argoff, American Academy of Pain Medicine Foundation

FDA Questions

Edward Michna, American Pain Society and Harvard Medical School

Debra Carr, Clinician

Gwenn Herman, Clinician

Hillary Kunins, New York City Department of Health and Mental Hygiene

FDA Questions

Panel 3

Andrew Kolodny, Physicians for Responsible Opioid Prescribing

Roland Gray, Clinician

Irfan Dhalla, University of Toronto and St. Michael’s Hospital

Michael Baron, Vanderbilt University

FDA Questions

Daniel Carr, American Society of Anesthesiologists

Michael Von Korff, Global Health Research Institute

Tara Gomes, Academia

Gregory Terman, University of Washington

FDA Questions

Panel 4

Stephen Wood, Covectra, Inc.

Matt Ervin, MedicaSafe, Inc.

Kevin Zacharoff, Inflexxion

Jody Green, Denver Health and Hospital Authority

FDA Questions

Jeffrey White, Worker’s Compensation Insurance Company

Leland McClure, Quest Diagnostics

G. Caleb Alexander, Academia

Daniel Solomon, Harvard Medical School and Brigham and Women’s Hospital

FDA Questions

Adjourn for Day 1

Day 2 Panel 5

Opening Remarks

Dennis Capolongo, Arachnoiditis Society for Awareness and Prevention

Andrew Kowal, Tufts Medical School and Lahey Clinic

William Schmidt, Industry Consultant

David Bagnall, American Academy of Physical Medicine and Rehabilitation

FDA Questions

Patricia McDonald, Patient Advocate

Tish Westrup, Patient Advocate

Judy Rummler, Steve Rummler Hope Foundation

Lexi Reed Holtum, Steve Rummler Hope Foundation

FDA Questions

Panel 6

Marianne Cloeren, American College of Occupational and Environmental Medicine

Jaime Threadgill, Pharmacist

Kevin Nicholson, National Association of Chain Drug Stores

Jack E. Henningfield, Pinney Associates

FDA Questions

David Egilman, Brown University

Miro Pavelka, American Association of Oral and Maxillofacial Surgeons

Richard Medlin, Academia and Clinician

Jane Ballantyne, Clinician

FDA Questions

Panel 7

Anita Roach, Interstitial Cystitis Association

Fred Brason, Project Lazarus

Rebecca Kirch, American Cancer Society

Robert O’Connor, Emergency Room Physician

FDA Questions

Cheryl Placek, Parent

Randy Cohen, Patient

FDA Questions

Open Public Hearing, Closing Remarks